Need for immunization against single bacterial diseases

Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z23 Cause of death: ICD-10 — Z23 2 out of 7 registries used, show all original rules.	100
4. Check minimum number of events None	100
5. Include endpoints None	100
6. Filter based on genotype QC (FinnGen only)	81

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z2

NAME	Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA
CONTROL_EXCLUDE	Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z23
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z23
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Need for immunization against single bacterial diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	81	48	33
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	38.04	29.55	50.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
100: Matched controls
1000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z23.2

ICD-10 Finland

Need for immunization against tuberculosis [BCG]

+∞

45.3

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

+∞

35.6

Z23.8

ICD-10 Finland

Need for immunization against other single bacterial diseases

+∞

23.9

WW200

NOMESCO Finland

Immunization

18.6

13.8

Z49.0

ICD-10 Finland

Preparatory care for dialysis

110.0

9.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

110.0

9.6

Z25.1

ICD-10 Finland

Need for immunization against influenza

13.3

8.4

TK800

NOMESCO Finland

Hemodialysis

24.4

8.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

14.9

7.6

V03AE02

ATC

sevelamer; oral

86.2

7.5

A11CC03

ATC

alfacalcidol; systemic

13.4

7.3

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

13.4

7.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

32.6

7.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

6.8

111

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Nephrology
39 [38004479]

3.2e+00

3.4e+00

—

1.0e+50

—

cases:19.35%

controls:0.97%

cases:20.31%

controls:0.79%

—

cases:17.19%

controls:0.00%

cases:14.52%

controls:0.00%

—

614

625

—

630

628

—

Scheduled procedure
ZXD10 [2001311387]

1.5e+00

2.4e+00

—

2.4e+00

—

cases:14.52%

controls:3.55%

cases:9.38%

controls:0.95%

—

cases:8.47%

controls:0.82%

—

598

624

—

604

—

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

7.0e-01

1.4e+00

2.2e+00

—

1.8e+00

—

cases:16.13%

controls:8.71%

cases:20.31%

controls:5.71%

cases:9.38%

controls:1.11%

—

cases:25.42%

controls:5.09%

—

566

594

623

—

578

—

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

1.4e+00

2.1e+00

—

3.2e+00

—

cases:9.68%

controls:2.58%

cases:12.50%

controls:1.75%

—

cases:25.42%

controls:1.31%

—

604

619

—

601

—

Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]

1.7e+00

2.2e+00

—

2.9e+00

—

cases:11.29%

controls:2.26%

cases:9.38%

controls:1.11%

—

cases:16.95%

controls:1.15%

—

606

623

—

602

—

Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]

1.6e+00

2.1e+00

—

2.7e+00

—

cases:11.29%

controls:2.42%

cases:9.38%

controls:1.27%

—

cases:16.95%

controls:1.31%

—

605

622

—

601

—

Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]

1.9e+00

2.2e+00

—

2.5e+00

—

cases:8.06%

controls:1.29%

cases:9.38%

controls:1.11%

—

cases:16.95%

controls:1.64%

—

612

623

—

599

—

Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]

1.5e+00

2.1e+00

—

2.5e+00

—

cases:11.29%

controls:2.74%

cases:9.38%

controls:1.27%

—

cases:16.95%

controls:1.64%

—

603

622

—

599

—

Medical doctor
Z2221 [2001311556]

1.8e+00

2.5e+00

—

cases:17.74%

controls:3.39%

cases:14.06%

controls:1.27%

—

599

622

—

Case Management Agency
251B00000X [38004193]

3.7e-01

-4.1e-02

1.7e-01

4.0e+00

8.5e-01

-1.3e-01

—

cases:82.26%

controls:76.29%

cases:67.19%

controls:68.10%

cases:31.25%

controls:27.78%

cases:42.19%

controls:1.27%

cases:40.32%

controls:22.45%

cases:67.80%

controls:70.61%

—

473

147

429

201

175

455

622

141

487

430

179

—

furosemide; oral, parenteral
C03CA01 [21601518]

1.9e+00

1.7e+00

—

1.5e+00

—

cases:16.13%

controls:2.90%

cases:14.06%

controls:2.86%

—

cases:11.86%

controls:2.79%

—

602

612

—

592

—

Inpatient Hospital
21 [8717]

4.0e-01

7.9e-01

—

2.1e+00

1.5e+00

—

cases:33.87%

controls:25.65%

cases:17.19%

controls:8.57%

—

cases:11.29%

controls:1.59%

cases:25.42%

controls:7.22%

—

159

461

576

—

618

565

—

Gastroenterology
10 [38004455]

1.4e+00

2.0e+00

—

1.5e+00

—

cases:19.35%

controls:5.81%

cases:15.63%

controls:2.38%

—

cases:10.17%

controls:2.46%

—

584

615

—

594

—

Short blood count panel - Blood
55429-5 [40758558]

3.2e-01

1.5e+00

—

1.8e+00

—

cases:8.06%

controls:5.97%

cases:15.63%

controls:3.81%

—

cases:22.03%

controls:4.43%

—

583

606

—

582

—

Thorax X-ray examination
GD1AA [2001303617]

1.2e+00

2.0e+00

—

1.2e+00

—

cases:22.58%

controls:7.74%

cases:18.75%

controls:3.02%

—

cases:8.47%

controls:2.63%

—

572

611

—

593

—

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

7.9e-01

1.5e+00

—

1.4e+00

—

cases:19.35%

controls:9.84%

cases:17.19%

controls:4.44%

—

cases:22.03%

controls:6.24%

—

559

602

—

571

—

Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]

1.2e+00

—

2.9e+00

—

cases:9.68%

controls:3.23%

—

cases:13.56%

controls:0.82%

—

600

—

604

—

Social worker
Z2446 [2001311559]

2.7e+00

—

cases:11.29%

controls:0.81%

—

615

—

Intravenous
ZX120 [2001311495]

2.7e+00

—

cases:12.90%

controls:0.97%

—

614

—

Infectious Disease
44 [38004484]

1.5e+00

—

1.0e+50

—

2.6e+00

—

cases:8.06%

controls:1.94%

—

cases:7.81%

controls:0.00%

—

cases:11.86%

controls:0.99%

—

608

—

630

—

603

—

Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]

2.6e+00

—

cases:14.52%

controls:1.29%

—

612

—

Lumbar spine X-ray examination without contrast
NA3AA [2001307026]

2.6e+00

—

cases:14.52%

controls:1.29%

—

612

—

Left side
ZXA05 [2001311347]

2.6e+00

2.0e+00

—

cases:12.90%

controls:1.13%

cases:7.81%

controls:1.11%

—

613

623

—

Outpatient Visit
OP [9202]

8.9e-01

5.8e-01

1.2e+00

1.0e+50

1.3e+00

7.9e-01

—

cases:88.71%

controls:76.29%

cases:64.06%

controls:49.84%

cases:25.00%

controls:9.05%

cases:37.50%

controls:0.00%

cases:25.81%

controls:8.60%

cases:66.10%

controls:46.96%

—

473

147

314

316

573

630

574

286

323

—

Monocytes/Leukocytes in Blood
26485-3 [3019069]

7.5e-01

1.1e+00

—

1.9e+00

1.3e+00

—

cases:22.58%

controls:12.10%

cases:21.88%

controls:8.25%

—

cases:8.06%

controls:1.27%

cases:23.73%

controls:7.88%

—

545

578

—

620

561

—

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]

—

2.4e+00

—

cases:8.47%

controls:0.82%

—

604

—

pH of Serum or Plasma
2753-2 [3018418]

—

1.2e+00

—

2.3e+00

—

cases:7.81%

controls:2.54%

—

cases:16.95%

controls:1.97%

—

614

—

597

—

Emergency Room Visit
ER [9203]

5.4e-01

1.1e+00

—

1.0e+50

1.7e+00

1.2e+00

—

cases:45.16%

controls:32.42%

cases:28.13%

controls:11.59%

—

cases:20.31%

controls:0.00%

cases:8.06%

controls:1.59%

cases:23.73%

controls:8.87%

—

201

419

557

—

630

618

555

—

Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]

1.3e+00

2.2e+00

—

cases:11.29%

controls:3.23%

cases:10.94%

controls:1.27%

—

600

622

—

Emergency Room and Inpatient Visit
ERIP [262]

8.5e-01

2.2e+00

—

cases:11.29%

controls:5.16%

cases:9.38%

controls:1.11%

—

588

623

—

Abdominal ultrasound examination
JN3AE [2001305555]

2.1e+00

—

cases:12.90%

controls:1.77%

—

609

—

Pharmacy visit
OMOP4822462 [581458]

5.2e-01

8.5e-01

-1.0e-01

2.0e+00

7.0e-01

6.3e-02

—

cases:96.77%

controls:94.68%

cases:92.19%

controls:83.49%

cases:42.19%

controls:44.76%

cases:14.06%

controls:2.06%

cases:61.29%

controls:44.11%

cases:84.75%

controls:83.91%

—

587

526

104

282

348

617

277

351

511

—

Physiotherapist
Z3226 [2001311560]

2.0e+00

—

cases:12.90%

controls:1.94%

—

608

—

Photography of fundus of eye
XCK10 [2001301381]

1.9e+00

—

cases:11.29%

controls:1.77%

—

609

—

Need for immunization against other specified single viral diseases
Z25.8 [45547296]

1.9e+00

2.4e+00

—

cases:17.74%

controls:3.06%

cases:7.81%

controls:0.79%

—

601

625

—

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

5.0e-01

1.1e+00

—

1.9e+00

—

cases:19.35%

controls:12.74%

cases:14.06%

controls:5.24%

—

cases:30.51%

controls:6.24%

—

541

597

—

571

—

Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]

5.1e-01

1.8e+00

—

cases:11.29%

controls:7.10%

cases:14.06%

controls:2.54%

—

576

614

—

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

5.6e-01

1.3e+00

—

1.8e+00

—

cases:14.52%

controls:8.87%

cases:17.19%

controls:5.56%

—

cases:20.34%

controls:3.94%

—

565

595

—

585

—

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

2.2e-02

1.0e+00

—

1.8e+00

—

cases:8.06%

controls:7.90%

cases:10.94%

controls:4.29%

—

cases:18.64%

controls:3.61%

—

571

603

—

587

—

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

9.0e-02

—

1.8e+00

—

cases:8.06%

controls:7.42%

—

cases:18.64%

controls:3.61%

—

574

—

587

—

Three-surface restoration
SFA30 [2001310360]

-1.1e-01

1.8e+00

—

cases:9.68%

controls:10.65%

cases:12.50%

controls:2.38%

—

554

615

—

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

—

1.8e+00

—

1.4e+00

—

cases:18.75%

controls:3.81%

—

cases:11.86%

controls:3.28%

—

606

—

589

—

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

2.6e-01

8.2e-01

1.7e+00

1.0e+50

1.4e+00

8.3e-01

—

cases:38.71%

controls:32.74%

cases:37.50%

controls:20.95%

cases:17.19%

controls:3.49%

cases:7.81%

controls:0.00%

cases:14.52%

controls:4.14%

cases:40.68%

controls:22.99%

—

203

417

132

498

608

630

602

140

469

—

Outpatient Hospital
22 [8756]

4.5e-01

9.3e-01

—

1.0e+50

—

1.7e+00

—

cases:29.03%

controls:20.65%

cases:15.63%

controls:6.83%

—

cases:7.81%

controls:0.00%

—

cases:23.73%

controls:5.25%

—

128

492

587

—

630

—

577

—

Right side
ZXA00 [2001311346]

1.7e+00

—

cases:12.90%

controls:2.58%

—

604

—

Epithelial cells [#/volume] in Urine
30383-4 [3000850]

8.5e-01

1.7e+00

—

cases:11.29%

controls:5.16%

cases:14.06%

controls:3.02%

—

588

611

—

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

1.0e-01

1.0e+00

—

1.6e+00

—

cases:12.90%

controls:11.77%

cases:14.06%

controls:5.56%

—

cases:27.12%

controls:6.73%

—

547

595

—

568

—

Differential panel, method unspecified - Blood
69738-3 [42870588]

6.8e-01

1.6e+00

—

1.3e+00

—

cases:14.52%

controls:7.90%

cases:17.19%

controls:3.97%

—

cases:15.25%

controls:4.60%

—

571

605

—

581

—

25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]

8.1e-01

1.5e+00

—

1.3e+00

—

cases:16.13%

controls:7.90%

cases:17.19%

controls:4.29%

—

cases:15.25%

controls:4.76%

—

571

603

—

580

—

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

6.4e-01

1.5e+00

—

1.3e+00

—

cases:14.52%

controls:8.23%

cases:18.75%

controls:4.92%

—

cases:13.56%

controls:3.94%

—

569

599

—

585

—

Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]

1.4e+00

1.0e+00

—

cases:19.35%

controls:5.81%

cases:9.38%

controls:3.49%

—

584

608

—

Normoblasts [#/volume] in Blood
715-3 [3021589]

2.9e-01

8.8e-01

—

1.4e+00

1.3e+00

—

cases:17.74%

controls:13.87%

cases:20.31%

controls:9.52%

—

cases:8.06%

controls:2.07%

cases:30.51%

controls:10.67%

—

534

570

—

615

544

—

Internal Medicine
11 [38004456]

9.1e-01

1.3e+00

—

1.0e+50

—

8.8e-01

—

cases:35.48%

controls:18.06%

cases:20.31%

controls:6.67%

—

cases:7.81%

controls:0.00%

—

cases:13.56%

controls:6.08%

—

112

508

588

—

630

—

572

—

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

7.4e-01

1.1e+00

—

1.9e+00

1.3e+00

—

cases:22.58%

controls:12.26%

cases:21.88%

controls:8.41%

—

cases:8.06%

controls:1.27%

cases:23.73%

controls:8.05%

—

544

577

—

620

560

—

Basophils/Leukocytes in Blood
30180-4 [3022096]

7.5e-01

1.1e+00

—

1.9e+00

1.3e+00

—

cases:22.58%

controls:12.10%

cases:21.88%

controls:8.57%

—

cases:8.06%

controls:1.27%

cases:23.73%

controls:8.05%

—

545

576

—

620

560

—

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

7.8e-01

1.1e+00

—

1.9e+00

1.2e+00

—

cases:22.58%

controls:11.77%

cases:21.88%

controls:8.41%

—

cases:8.06%

controls:1.27%

cases:23.73%

controls:8.21%

—

547

577

—

620

559

—

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

4.9e-01

1.0e+00

—

1.3e+00

1.2e+00

—

cases:22.58%

controls:15.16%

cases:23.44%

controls:9.68%

—

cases:8.06%

controls:2.23%

cases:27.12%

controls:9.69%

—

526

569

—

614

550

—

Monocytes [#/volume] in Blood
26484-6 [3001604]

6.5e-01

1.1e+00

—

1.8e+00

1.2e+00

—

cases:22.58%

controls:13.23%

cases:21.88%

controls:8.41%

—

cases:8.06%

controls:1.43%

cases:25.42%

controls:9.20%

—

538

577

—

619

553

—

Infiltration anesthesia
WX110 [2001310767]

2.0e-01

1.2e+00

-1.0e+50

—

6.2e-01

—

cases:27.42%

controls:23.71%

cases:21.88%

controls:7.78%

cases:0.00%

controls:1.11%

—

cases:16.95%

controls:9.85%

—

147

473

581

623

—

549

—

Basophils [#/volume] in Blood
26444-0 [3006315]

6.4e-01

1.1e+00

—

1.8e+00

1.2e+00

—

cases:22.58%

controls:13.39%

cases:21.88%

controls:8.57%

—

cases:8.06%

controls:1.43%

cases:25.42%

controls:9.36%

—

537

576

—

619

552

—

Eosinophils [#/volume] in Blood
26449-9 [3013115]

5.8e-01

9.8e-01

—

1.8e+00

1.2e+00

—

cases:22.58%

controls:14.03%

cases:21.88%

controls:9.52%

—

cases:8.06%

controls:1.43%

cases:25.42%

controls:9.52%

—

533

570

—

619

551

—

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

2.1e-01

9.5e-01

1.9e+00

—

1.2e+00

—

cases:24.19%

controls:20.48%

cases:26.56%

controls:12.22%

cases:7.81%

controls:1.27%

—

cases:32.20%

controls:12.81%

—

127

493

553

622

—

531

—

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

6.5e-01

1.0e+00

—

1.8e+00

1.2e+00

—

cases:22.58%

controls:13.23%

cases:21.88%

controls:9.05%

—

cases:8.06%

controls:1.43%

cases:25.42%

controls:9.69%

—

538

573

—

619

550

—

Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]

-1.6e-01

1.9e-01

—

1.0e+00

—

cases:27.42%

controls:30.81%

cases:18.75%

controls:16.03%

—

cases:35.59%

controls:16.91%

—

191

429

101

529

—

103

506

—

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

-1.4e-01

3.5e-01

8.0e-01

—

1.0e+00

9.4e-01

—

cases:27.42%

controls:30.32%

cases:29.69%

controls:23.02%

cases:10.94%

controls:5.24%

—

cases:12.90%

controls:4.94%

cases:45.76%

controls:24.79%

—

188

432

145

485

597

—

597

151

458

—

Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Urology
34 [38004474]

3.8e-01

—

-1.0e+50

—

cases:8.06%

controls:5.65%

—

cases:0.00%

controls:1.11%

—

585

—

623

—

SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 [2002330113]

—

-1.0e+50

—

cases:0.00%

controls:2.54%

—

614

—

Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Hip extensive X-ray examination
NF1BA [2001307899]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

plastic IUD with progestogen; implant
G02BA03 [21602449]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.99%

—

625

—

603

—

Pathology report gross observation
24419-4 [3002256]

—

-1.0e+50

—

cases:0.00%

controls:0.95%

—

624

—

Other complicated root filling
SGB30 [2001310390]

-1.0e+50

—

cases:0.00%

controls:2.10%

—

607

—

Other obesity
E66.8 [45533036]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Psychiatry
26 [38004469]

1.9e-01

—

-1.0e+50

—

cases:8.06%

controls:6.77%

—

cases:0.00%

controls:1.90%

—

578

—

618

—

Supervision of other normal pregnancy
Z34.8 [45537628]

-1.0e+50

—

cases:0.00%

controls:2.58%

—

604

—

pH of Venous blood
2746-6 [3012544]

2.0e+00

—

cases:9.68%

controls:1.45%

—

611

—

Osteoarthrosis of hip
L89 [2002000708]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Pulpit UNS
K04.09 [2000502704]

-1.0e+50

—

cases:0.00%

controls:1.77%

—

609

—

Obesity due to excess calories
E66.01 [2000501501]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.29%

cases:0.00%

controls:1.27%

—

cases:0.00%

controls:1.31%

—

612

622

—

601

—

Extensive examination of musculoskeletal system
SPAT1212 [2001700313]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

fluticasone, combinations
R01AD58 [43534837]

1.0e+00

—

cases:9.68%

controls:3.71%

—

597

—

INR in Blood by Coagulation assay
34714-6 [3032080]

4.1e-01

1.1e+00

—

1.1e+00

—

cases:14.52%

controls:10.16%

cases:12.50%

controls:4.44%

—

cases:11.86%

controls:4.43%

—

557

602

—

582

—

fluticasone furoate
R03BA09 [45893496]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

cases:0.00%

controls:1.48%

—

621

—

600

—

C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30522-7 [3010156]

-1.0e+50

—

cases:0.00%

controls:0.97%

cases:0.00%

controls:0.79%

—

614

625

—

Elevated blood pressure
K85 [2002000612]

-1.0e+50

—

cases:0.00%

controls:2.42%

—

605

—

metronidazole and furazolidone
P01AB51 [45893518]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Hordeolum
H00.00 [2000502235]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Preventive immunization/medic
-44 [2002000115]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

fluconazole; oral, parenteral
J02AC01 [21603080]

1.1e+00

—

cases:16.13%

controls:6.13%

—

582

—

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:1.31%

—

624

—

601

—

HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]

7.1e-01

1.2e+00

—

1.8e+00

—

cases:12.90%

controls:6.77%

cases:7.81%

controls:2.54%

—

cases:10.17%

controls:1.81%

—

578

614

—

598

—

Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

Comprehensive monitoring of chronic illness
SPAT1250 [2001700351]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:5.16%

cases:0.00%

controls:2.38%

—

cases:0.00%

controls:0.96%

cases:0.00%

controls:2.13%

—

588

615

—

622

596

—

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

intermediate-acting sulfonamides - combinations
J01EC20 [21602948]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

antibiotics in combination with other drugs
S01AA20 [21603571]

2.4e-01

-1.0e+50

—

-1.0e+50

—

cases:8.06%

controls:6.45%

cases:0.00%

controls:1.59%

—

cases:0.00%

controls:1.97%

—

580

620

—

597

—

Vomiting
D10 [2002000309]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]

7.8e-01

—

cases:8.06%

controls:3.87%

—

596

—

sulfadiazine and trimethoprim
J01EE02 [21602962]

—

-1.0e+50

—

cases:0.00%

controls:0.99%

—

603

—

Plastic And Reconstructive Surgery
24 [38004467]

—

2.0e+00

—

cases:7.81%

controls:1.11%

—

623

—

Psychological sympt/compl other
P29 [2002000823]

-1.0e+50

—

cases:0.00%

controls:1.61%

—

610

—

Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Sinus symptom/complaint
R09 [2002000890]

-1.0e+50

—

cases:0.00%

controls:2.10%

—

607

—

salmeterol; inhalant
R03AC12 [21603266]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Check up of cardiac pacemaker
XFP20 [2001303367]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Recording of ECG
SPAT1097 [2001700198]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]

-1.0e+50

—

cases:0.00%

controls:1.94%

—

608

—

Conjunctivitis
H10 [45581570]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

Medical Oncology
90 [38004507]

-1.0e+50

—

cases:0.00%

controls:2.74%

—

603

—

chloramphenicol
S01AA01 [21603554]

1.7e-01

—

-1.0e+50

—

cases:11.29%

controls:9.68%

—

cases:0.00%

controls:1.11%

—

560

—

623

—

Leukocytes [#/volume] in Urine
30405-5 [3018095]

6.4e-01

1.3e+00

—

1.3e+00

—

cases:16.13%

controls:9.19%

cases:17.19%

controls:5.40%

—

cases:15.25%

controls:4.60%

—

563

596

—

581

—

Functional dyspepsia
K30 [45591584]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

9.8e-03

7.8e-01

—

4.4e-01

—

cases:20.97%

controls:20.81%

cases:14.06%

controls:6.98%

—

cases:15.25%

controls:10.34%

—

129

491

586

—

546

—

Opening and preparing the root canals, complicated
SGA03 [2001310381]

-1.0e+50

—

cases:0.00%

controls:1.94%

—

608

—

Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

prednisolone
S03BA02 [21605202]

-1.0e+50

—

cases:0.00%

controls:1.94%

—

608

—

Specific gravity of Urine by Refractometry
5810-7 [3019150]

2.4e-01

—

cases:8.06%

controls:6.45%

—

580

—

combinations of corticosteroids
D07XB30 [21602188]

3.7e-01

—

cases:14.52%

controls:10.48%

—

555

—

glucosamine; oral
M01AX05 [21604002]

-1.0e+50

—

cases:0.00%

controls:1.61%

cases:0.00%

controls:1.43%

—

610

621

—

dexamethasone
S01BA01 [21603618]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:1.15%

—

625

—

602

—

meloxicam; oral, parenteral, rectal
M01AC06 [21603965]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.82%

—

625

—

604

—

ethylmorphine; oral
R05DA01 [21603397]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

cases:0.00%

controls:1.81%

—

623

—

598

—

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Other primary coxarthrosis
M16.1 [45591741]

-1.0e+50

—

cases:0.00%

controls:2.10%

cases:0.00%

controls:0.79%

—

607

625

—

clarithromycin; oral, parenteral
J01FA09 [21602977]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

623

—

Cystitis
N30 [45563012]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

After-cataract
H26.4 [45600893]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Dental caries
K02 [45552906]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

1.0e-01

8.8e-01

—

1.3e+00

—

cases:11.29%

controls:10.32%

cases:9.38%

controls:4.13%

—

cases:11.86%

controls:3.61%

—

556

604

—

587

—

Physiotherapy
R4110 [2001310233]

8.5e-01

—

cases:9.68%

controls:4.35%

—

593

—

candesartan; oral
C09CA06 [21601829]

—

-1.0e+50

—

6.9e-01

—

cases:0.00%

controls:1.43%

—

cases:8.47%

controls:4.43%

—

621

—

582

—

bupropion; oral
N06AX12 [21604741]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

cases:0.00%

controls:1.48%

—

621

—

600

—

Acute and subacute iridocyclitis
H20.0 [45542994]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

insulin detemir; parenteral
A10AE05 [21600740]

—

-1.0e+50

—

cases:0.00%

controls:0.96%

—

622

—

lactulose; oral
A06AD11 [21600571]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

Lump/swelling localized
S04 [2002000969]

-1.0e+50

—

cases:0.00%

controls:0.81%

cases:0.00%

controls:0.79%

—

615

625

—

sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]

—

-1.0e+50

—

cases:0.00%

controls:1.59%

—

620

—

Fracture of tooth, open
S02.51 [45755762]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

hydrocortisone and antiinfectives
S03CA04 [21605208]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.26%

—

cases:0.00%

controls:0.99%

—

606

—

603

—

enalapril and diuretics
C09BA02 [21601804]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.45%

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:1.15%

—

611

624

—

602

—

diphenhydramine, combinations
R06AA52 [21603454]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Two-surface restoration
SFA20 [2001310359]

-2.2e-01

—

9.2e-02

—

cases:19.35%

controls:23.06%

—

cases:10.17%

controls:9.36%

—

143

477

—

552

—

Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Primary total prosthetic replacement of hip joint not using cement
NFB30 [2001307921]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]

1.4e+00

—

-1.0e+50

—

cases:8.06%

controls:2.10%

—

cases:0.00%

controls:1.64%

—

607

—

599

—

enalapril; oral, parenteral
C09AA02 [21601786]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.22%

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.80%

—

616

625

—

623

—

Palpitations/awareness of heart
K04 [2002000547]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Thrombin time
3243-3 [3036489]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

General Surgery
2 [38004447]

4.1e-01

6.4e-01

-1.0e+50

—

1.3e+00

—

cases:19.35%

controls:13.71%

cases:7.81%

controls:4.29%

cases:0.00%

controls:0.79%

—

cases:13.56%

controls:3.94%

—

535

603

625

—

585

—

Procedure duration 10 to 19 minutes
ZXE02 [2001311396]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]

-1.0e+50

—

cases:0.00%

controls:1.61%

—

610

—

Pulp capping
SGC10 [2001310393]

—

-1.0e+50

—

cases:0.00%

controls:0.99%

—

603

—

Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

insulin aspart; parenteral
A10AD05 [21600733]

6.8e-01

8.3e-01

—

-1.0e+50

8.8e-01

—

cases:9.68%

controls:5.16%

cases:10.94%

controls:5.08%

—

cases:0.00%

controls:1.27%

cases:11.86%

controls:5.25%

—

588

598

—

620

577

—

Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

Mixed anxiety and depressive disorder
F41.2 [45566845]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:1.48%

—

625

—

600

—

Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

cough suppressants and mucolytics
R05FB01 [21603441]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

amitriptyline; oral, parenteral
N06AA09 [21604696]

8.2e-01

-1.0e+50

—

-1.0e+50

—

cases:8.06%

controls:3.71%

cases:0.00%

controls:2.54%

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.80%

cases:0.00%

controls:2.79%

—

597

614

625

—

623

592

—

12 lead EKG panel
34534-8 [3044889]

-6.5e-02

—

5.4e-01

—

cases:17.74%

controls:18.71%

—

cases:16.95%

controls:10.67%

—

116

504

—

544

—

Type 1 diabetes mellitus
E10 [45576436]

-1.0e+50

—

cases:0.00%

controls:1.13%

cases:0.00%

controls:0.79%

—

613

625

—

Free T4 and TSH panel - Serum or Plasma
24348-5 [3001019]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

nystatin
D01AA01 [21601911]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

cefadroxil; oral
J01DB05 [21602874]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]

1.0e+00

—

cases:9.68%

controls:3.71%

—

597

—

prednisolone
S01BA04 [21603621]

-1.0e+50

—

cases:0.00%

controls:1.94%

—

608

—

Hospital outpatient
ZY010 [2001311599]

-1.0e+50

—

cases:0.00%

controls:1.29%

cases:0.00%

controls:0.79%

—

612

625

—

Cardiorespiratory global assessment
SPAT1081 [2001700182]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
190 [2001600189]

1.0e+50

—

cases:8.06%

controls:0.00%

—

620

—

Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]

-1.0e+50

—

cases:0.00%

controls:1.94%

cases:0.00%

controls:1.11%

—

608

623

—

Specific gravity of Urine by Test strip
5811-5 [3000330]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.13%

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.99%

—

613

625

—

603

—

omeprazole; oral, parenteral
A02BC01 [21600096]

1.4e+00

—

cases:11.29%

controls:2.90%

—

602

—

hydroxocobalamin
V03AB33 [21605256]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Coxarthrosis, unspecified
M16.9 [45591742]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Other health check-up
SPAT1370 [2001700471]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]

1.8e+00

—

cases:8.06%

controls:1.45%

—

611

—

Application of cast or individual aid
SPAT1210 [2001700311]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Hand/finger symptom/complaint
L12 [2002000636]

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

621

—

Pap smear
SPAT1193 [2001700294]

-1.0e+50

—

cases:0.00%

controls:1.77%

cases:0.00%

controls:0.79%

—

609

625

—

More than one and less than three hours
ZXE10 [2001311401]

9.9e-01

1.6e+00

—

cases:11.29%

controls:4.52%

cases:7.81%

controls:1.75%

—

592

619

—

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

5.9e-01

—

1.3e+00

—

cases:12.90%

controls:7.58%

—

cases:11.86%

controls:3.45%

—

573

—

588

—

hydrocortisone and antiinfectives
S02CA03 [21605175]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.26%

—

cases:0.00%

controls:0.99%

—

606

—

603

—

Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

apixaban; oral
B01AF02 [43534762]

-1.0e+50

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.77%

—

cases:0.00%

controls:1.43%

—

cases:0.00%

controls:1.27%

—

609

—

621

—

620

—

Restoration involving the entire crown of the tooth
SFA40 [2001310361]

—

-1.0e+50

—

cases:0.00%

controls:1.81%

—

598

—

Caries limited to enamel
K02.0 [45576967]

—

-1.0e+50

—

cases:0.00%

controls:1.81%

—

598

—

Counselling related to known health issue
SPAT1310 [2001700411]

—

-1.0e+50

—

cases:0.00%

controls:2.06%

—

617

—

Therapeutic discussion
SPAT1240 [2001700341]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.58%

cases:0.00%

controls:1.11%

—

cases:0.00%

controls:0.80%

cases:0.00%

controls:1.48%

—

604

623

—

623

600

—

Acute upper respiratory infection, unspecified
J06.9 [45562437]

4.5e-01

6.6e-01

—

cases:16.13%

controls:10.97%

cases:9.38%

controls:5.08%

—

552

598

—

Urgent procedure
ZXD05 [2001311386]

6.4e-01

—

cases:9.68%

controls:5.32%

—

587

—

fluticasone; inhalant
R03BA05 [21603288]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.59%

—

cases:0.00%

controls:1.64%

—

620

—

599

—

Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

levonorgestrel
G03AC03 [21602499]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Psychosocial counselling and guidance
SPAT1307 [2001700408]

-1.0e+50

—

cases:0.00%

controls:1.94%

—

608

—

Migraine with aura [classical migraine]
G43.1 [45562086]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Maternal care due to uterine scar from previous surgery
O34.2 [45572805]

-1.0e+50

—

cases:0.00%

controls:1.29%

—

612

—

Angiography of heart and/or coronary arteries
FN1AC [2001302996]

-1.0e+50

—

cases:0.00%

controls:2.26%

—

606

—

pneumococcus, purified polysaccharides antigen conjugated
J07AL02 [21601313]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Unspecified nonorganic psychosis
F29 [45533099]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Person encountering health services in unspecified circumstances
Z76.9 [45609967]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.81%

—

cases:0.00%

controls:0.99%

—

615

—

603

—

Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.90%

—

cases:0.00%

controls:1.15%

—

602

—

602

—

Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]

3.4e-01

3.0e-01

—

3.8e-01

—

cases:35.48%

controls:28.23%

cases:21.88%

controls:17.14%

—

cases:28.81%

controls:21.67%

—

175

445

108

522

—

132

477

—

Inpatient Visit
IP [9201]

—

-1.0e+50

—

1.5e+00

—

cases:0.00%

controls:1.90%

—

cases:8.47%

controls:1.97%

—

618

—

597

—

Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

-1.1e-01

3.0e-01

1.2e+00

—

5.7e-01

7.3e-01

—

cases:38.71%

controls:41.45%

cases:37.50%

controls:30.79%

cases:14.06%

controls:4.60%

—

cases:11.29%

controls:6.69%

cases:50.85%

controls:33.33%

—

257

363

194

436

601

—

586

203

406

—

Outcome of delivery
Z37 [45581024]

2.2e-02

—

cases:8.06%

controls:7.90%

—

571

—

covid-19, RNA-based vaccine
J07BN01 [954934]

2.9e-01

2.4e-01

—

cases:32.26%

controls:26.29%

cases:14.06%

controls:11.43%

—

163

457

558

—

cetirizine; oral
R06AE07 [21603497]

-6.3e-02

1.3e+00

—

9.7e-01

—

cases:8.06%

controls:8.55%

cases:7.81%

controls:2.22%

—

cases:10.17%

controls:4.11%

—

567

616

—

584

—

Insect bite/sting
S12 [2002000977]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

diclofenac
D11AX18 [21602355]

—

-1.0e+50

—

cases:0.00%

controls:0.99%

—

603

—

Melanocytic naevi
D22 [45595739]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

desloratadine; oral
R06AX27 [21603526]

6.1e-01

9.5e-01

-1.0e+50

—

7.3e-01

—

cases:11.29%

controls:6.45%

cases:7.81%

controls:3.17%

cases:0.00%

controls:0.95%

—

cases:8.47%

controls:4.27%

—

580

610

624

—

583

—

orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]

5.3e-01

-1.0e+50

—

cases:11.29%

controls:6.94%

cases:0.00%

controls:3.49%

—

577

608

—

Upper gastrointestinal surgery
106 [44777669]

1.4e-01

—

1.5e+00

—

cases:9.68%

controls:8.55%

—

cases:11.86%

controls:2.96%

—

567

—

591

—

One hour or less
ZXE00 [2001311394]

1.1e+00

—

1.7e+00

—

cases:16.13%

controls:5.81%

—

cases:8.47%

controls:1.64%

—

584

—

599

—

cyproterone and estrogen
G03HB01 [21602617]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.61%

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:0.99%

—

610

624

—

603

—

Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]

—

-1.0e+50

—

cases:0.00%

controls:3.02%

—

611

—

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

-2.4e-01

3.5e-01

—

6.8e-01

—

cases:11.29%

controls:13.87%

cases:10.94%

controls:7.94%

—

cases:15.25%

controls:8.37%

—

534

580

—

558

—

Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Electrocardiogram with exercise test
46136006 [4261794]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Other somatoform disorders
F45.8 [45600750]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Otitis externa
H60 [45581713]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Localized swelling, mass and lump, unspecified
R22.9 [45577788]

-1.0e+50

—

cases:0.00%

controls:0.97%

cases:0.00%

controls:0.79%

—

614

625

—

Albumin [Mass/volume] in Urine
1754-1 [3012516]

4.9e-01

7.6e-01

—

3.7e-01

—

cases:9.68%

controls:6.13%

cases:7.81%

controls:3.81%

—

cases:10.17%

controls:7.22%

—

582

606

—

565

—

Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

terbinafine; ointment
D01AE15 [21601954]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Body height measure
50373000 [4177340]

-9.0e-01

—

-1.0e+50

—

cases:9.68%

controls:20.81%

—

cases:0.00%

controls:0.79%

—

129

491

—

625

—

Ear pain/earache
H01 [2002000475]

—

-1.0e+50

—

cases:0.00%

controls:0.95%

—

624

—

Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]

-1.0e+50

—

cases:0.00%

controls:2.10%

—

607

—

sitagliptin; oral
A10BH01 [21600784]

—

-1.0e+50

—

cases:0.00%

controls:0.95%

—

624

—

azelastine; nasal
R01AC03 [21605035]

1.0e+00

—

cases:9.68%

controls:3.71%

—

597

—

Audiometric test
21727005 [4071702]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Hearing complaint
H02 [2002000476]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Cryotherapy
ZXC50 [2001311370]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Dorsalgia
M54 [45553203]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]

—

1.0e+50

—

cases:8.47%

controls:0.00%

—

609

—

prednisolone; oral, parenteral
H02AB06 [21602734]

3.7e-01

—

-1.0e+50

—

-1.0e+50

—

cases:14.52%

controls:10.48%

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.96%

—

555

—

625

—

622

—

boric acid
S02AA03 [21605149]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Preparatory care for dialysis
Z49.0 [45571361]

1.0e+50

—

cases:11.29%

controls:0.00%

—

620

—

Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

Opening and preparing the root canals, extremely complicated And time consuming
SGA05 [2001310383]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]

2.1e-01

1.8e+00

—

1.1e+00

—

cases:11.29%

controls:9.35%

cases:9.38%

controls:1.75%

—

cases:8.47%

controls:2.96%

—

562

619

—

591

—

CBC panel - Blood by Automated count
58410-2 [40761511]

-2.8e-02

-1.9e-01

—

2.7e-01

—

cases:35.48%

controls:36.13%

cases:20.31%

controls:23.49%

—

cases:32.20%

controls:26.60%

—

224

396

148

482

—

162

447

—

Plugged feeling ear
H13 [2002000480]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

cases:0.00%

controls:0.82%

—

621

—

604

—

flumetasone and antiinfectives
S02CA02 [21605174]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Cathetrisation of vein
TPH04 [2001309597]

—

2.4e+00

—

cases:7.81%

controls:0.79%

—

625

—

insulin aspart; parenteral
A10AB05 [21600719]

6.8e-01

8.3e-01

—

-1.0e+50

8.8e-01

—

cases:9.68%

controls:5.16%

cases:10.94%

controls:5.08%

—

cases:0.00%

controls:1.27%

cases:11.86%

controls:5.25%

—

588

598

—

620

577

—

acrivastine; oral
R06AX18 [21603518]

—

-1.0e+50

—

cases:0.00%

controls:3.17%

—

610

—

lercanidipine; oral
C08CA13 [21601759]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

621

—

diclofenac; ointment
M02AA15 [21604051]

—

-1.0e+50

—

cases:0.00%

controls:0.99%

—

603

—

sertraline; oral
N06AB06 [21604714]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.90%

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.96%

—

618

625

—

622

—

Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Place of Employment-Worksite
18 [581475]

—

-1.0e+50

—

cases:0.00%

controls:1.15%

—

602

—

Thorax X-ray examination outside radiological department
GD1UA [2001303652]

1.5e+00

—

cases:9.68%

controls:2.26%

—

606

—

FVC percent change Respiratory system
69982-7 [42868471]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

telmisartan; oral
C09CA07 [21601830]

—

-1.0e+50

—

cases:0.00%

controls:0.82%

—

604

—

formoterol, glycopyrronium bromide and budesonide
R03AL11 [715850]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.29%

—

cases:0.00%

controls:0.82%

—

612

—

604

—

Irradiated enamel
K03.80 [2000502698]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Intensive care
WX872 [2001310844]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Shoulder symptom/complaint
L08 [2002000632]

—

-1.0e+50

—

cases:0.00%

controls:2.22%

—

616

—

Base excess in Venous blood by calculation
1927-3 [3002032]

1.9e+00

—

cases:8.06%

controls:1.29%

—

612

—

Periodontal treatment, very brief
SDA01 [2001310326]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

cases:0.00%

controls:1.31%

—

623

—

601

—

Tissue Pathology biopsy report
66121-5 [40768804]

7.0e-01

—

cases:14.52%

controls:7.74%

—

572

—

ABO and Rh group [Type] in Blood
882-1 [3003694]

1.4e-01

—

1.8e+00

—

cases:8.06%

controls:7.10%

—

cases:10.17%

controls:1.81%

—

576

—

598

—

Protein [Presence] in Urine by Test strip
20454-5 [3014051]

—

1.0e+00

—

cases:8.47%

controls:3.28%

—

589

—

paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]

7.3e-01

-1.0e+50

—

cases:8.06%

controls:4.03%

cases:0.00%

controls:1.75%

—

595

619

—

Essential (primary) hypertension
I10 [45591453]

4.7e-01

1.9e-01

—

5.6e-01

—

cases:19.35%

controls:13.06%

cases:10.94%

controls:9.21%

—

cases:13.56%

controls:8.21%

—

539

572

—

559

—

losartan and diuretics
C09DA01 [21601834]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.74%

cases:0.00%

controls:1.90%

—

cases:0.00%

controls:1.81%

—

603

618

—

598

—

Unspecified injury of lower leg
S89.9 [45603812]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Otolaryngology
4 [38004449]

3.3e-01

—

1.5e+00

—

cases:11.29%

controls:8.39%

—

cases:13.56%

controls:3.45%

—

568

—

588

—

Pain in joint
M25.5 [45586941]

1.2e+00

—

-1.0e+50

—

cases:12.90%

controls:4.19%

—

cases:0.00%

controls:1.97%

—

594

—

597

—

Memory test
SPAT1053 [2001700154]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

Removal of sutures
SPAT1153 [2001700254]

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

621

—

metronidazole; oral, rectal
P01AB01 [21604857]

2.1e-01

—

cases:8.06%

controls:6.61%

—

579

—

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

-9.9e-02

2.2e-01

—

-4.7e-02

—

cases:22.58%

controls:24.35%

cases:12.50%

controls:10.32%

—

cases:13.56%

controls:14.12%

—

151

469

565

—

523

—

Operative extraction of tooth
EBA10 [2001301925]

—

-1.0e+50

—

cases:0.00%

controls:1.31%

—

601

—

Excessive ear wax
H81 [2002000536]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:0.99%

—

624

—

603

—

hydroxyzine; oral, parenteral
N05BB01 [21604590]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.27%

—

cases:0.00%

controls:1.64%

—

622

—

599

—

Phase of life problem adult
P25 [2002000820]

-1.0e+50

—

cases:0.00%

controls:1.13%

—

613

—

dexamethasone; oral, parenteral
H02AB02 [21602730]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

cases:0.00%

controls:0.82%

—

625

—

604

—

fexofenadine; oral
R06AX26 [21603525]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

Nonorganic insomnia
F51.0 [45552492]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

cases:0.00%

controls:1.64%

—

621

—

599

—

Osmolality of Urine
2695-5 [3026782]

—

1.2e+00

—

cases:7.81%

controls:2.38%

—

615

—

Chronic apical periodontitis
K04.5 [45586691]

4.8e-01

—

-1.0e+50

—

cases:8.06%

controls:5.16%

—

cases:0.00%

controls:1.64%

—

588

—

599

—

empagliflozin; oral
A10BK03 [1123740]

-1.0e+50

—

cases:0.00%

controls:1.45%

—

611

—

Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]

-3.9e-02

6.0e-02

-1.0e+50

—

-1.4e-01

—

cases:29.03%

controls:29.84%

cases:17.19%

controls:16.35%

cases:0.00%

controls:1.75%

—

cases:18.64%

controls:20.85%

—

185

435

103

527

619

—

127

482

—

Dental examination
Z01.2 [45581002]

3.3e-02

—

cases:11.29%

controls:10.97%

—

552

—

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

losartan; oral
C09CA01 [21601824]

—

-1.0e+50

—

cases:0.00%

controls:1.59%

—

618

—

hydroxocobalamin; parenteral
B03BA03 [21601123]

-1.0e+50

—

cases:0.00%

controls:0.97%

—

614

—

Diabetes, non-insulin-treated
215 [2001600211]

—

-1.0e+50

—

cases:0.00%

controls:0.79%

—

625

—

Physical Medicine And Rehabilitation
25 [38004468]

5.9e-01

—

cases:12.90%

controls:7.58%

—

573

—

Anxiety disorder/anxiety state
P74 [2002000868]

-1.0e+50

—

cases:0.00%

controls:0.81%

—

615

—

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

313

2.91

6.41

7.2

4.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

+∞

6.31

13.3

0.0

3.02

—

mmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

298

2.66

5.44

8.9

4.0

12.81

244.36

e6/l

0.52

219

(3003458) Phosphate [Moles/volume] in Serum or Plasma

198

2.70

5.27

25.3

12.0

1.20

1.34

mmol/l

1.54

190

(3018095) Leukocytes [#/volume] in Urine

354

2.63

5.25

10.1

4.9

40.75

31.56

e6/l

0.18

229

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

179

2.69

5.07

6.1

3.9

3.92

2.29

e6/l

0.31

(3025941) Bacteria identified in Stool by Culture

4.34

4.43

1.3

1.2

—

(3018418) pH of Serum or Plasma

200

2.45

4.27

15.2

4.1

7.40

7.39

0.32

135

(3030467) Casts [#/volume] in Urine by Automated count

273

2.27

3.86

8.1

3.9

0.61

0.41

e6/l

0.18

189

(3017143) Hepatitis C virus Ab [Presence] in Serum

135

2.49

3.74

3.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2.80

3.66

18.7

21.0

1.47

1.18

mg/l

0.95

(40768446) Kidney Pathology biopsy report

8.26

3.62

2.1

3.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

6.58

3.58

6.9

8.5

9.17

9.40

mg/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.30

3.57

3.7

2.2

—

(3000991) Gas panel - Venous blood

171

2.28

3.38

32.6

12.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.32

3.18

1.6

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.32

3.18

1.6

1.5

—

(40758558) Short blood count panel - Blood

309

2.06

3.12

9.2

7.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.60

3.07

1.3

1.7

—

(3012544) pH of Venous blood

185

2.17

3.07

23.2

13.3

7.37

0.13

118

(3021447) Carbon dioxide [Partial pressure] in Venous blood

185

2.17

3.07

22.6

12.8

6.01

5.63

kpa

2.18

185

(3048689) Calprotectin [Mass/mass] in Stool

163

2.20

3.01

2.4

2.7

58.64

89.50

ug/g

0.76

130

(3026008) Bacteria identified in Urine by Culture

204

2.10

2.94

3.3

2.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

173

2.15

2.90

10.1

12.8

6.56

5.28

kpa

0.89

173

(3021589) Normoblasts [#/volume] in Blood

476

2.04

2.88

15.6

12.2

0.00

0.03

e9/l

0.50

336

(46235355) HIV 1 and 2 tests - Meaningful Use set

206

2.08

2.85

3.0

2.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

191

2.09

2.80

5.9

3.8

0.82

0.81

e6/l

0.01

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

3.40

2.74

2.5

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

443

1.97

2.70

5.8

3.6

0.00

estimate

—

(4035726) Immunohistochemistry procedure

2.62

2.61

1.6

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

126

2.19

2.59

3.5

2.0

—

(42870588) Differential panel, method unspecified - Blood

380

1.92

2.59

15.2

10.5

—

(3044640) Blood type and Crossmatch panel - Blood

255

1.95

2.57

5.3

3.1

—

(3009261) Glucose [Presence] in Urine by Test strip

449

1.92

2.53

5.8

3.6

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

449

1.92

2.53

5.7

3.6

0.00

estimate

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

174

2.03

2.51

13.3

11.8

23.67

23.01

mmol/l

0.62

174

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

128

2.15

2.49

3.2

1.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.83

2.46

3.2

2.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

303

1.88

2.43

2.1

1.7

1.76

1.71

g/l

0.09

159

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

177

1.99

2.38

2.7

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.43

2.37

2.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

4.83

2.30

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

4.10

2.29

1.0

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.70

2.28

2.2

3.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

156

2.00

2.26

13.0

9.8

0.80

0.81

mmol/l

0.15

149

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

156

2.00

2.26

3.4

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

213

1.90

2.26

5.6

3.0

—

(3042733) HLA Ab [Presence] in Serum

5.78

2.24

6.8

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.88

2.19

2.0

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

250

1.84

2.16

3.9

3.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

120

2.07

2.14

14.3

16.3

102.95

105.07

mmol/l

1.07

120

(3006315) Basophils [#/volume] in Blood

524

1.84

2.14

13.2

9.6

0.04

e9/l

0.54

414

(3001604) Monocytes [#/volume] in Blood

524

1.84

2.14

13.2

9.6

0.68

0.59

e9/l

0.77

416

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

5.20

2.09

1.4

2.5

2.72

1.83

nmol/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.31

2.04

3.3

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2.73

2.01

2.5

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

4.72

1.96

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

728

2.12

1.94

4.3

3.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

2.56

1.93

3.5

2.2

111.60

129.52

au/ml

—

(3013115) Eosinophils [#/volume] in Blood

544

1.78

1.91

14.6

10.1

0.21

e9/l

0.02

445

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.01

1.91

2.6

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

454

1.73

1.90

35.5

14.7

1.23

mmol/l

0.44

426

(3014111) Lactate [Moles/volume] in Serum or Plasma

103

2.04

1.87

36.6

20.1

1.37

1.24

mmol/l

0.20

103

(3016650) Hepatitis A virus Ab [Presence] in Serum

3.68

1.86

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.72

1.85

1.6

2.1

92.56

19.11

ng/l

—

(3019198) Lymphocytes [#/volume] in Blood

537

1.75

1.84

13.3

9.6

2.38

2.33

e9/l

0.07

446

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.19

1.83

4.4

5.0

27.43

30.30

umol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.39

1.82

3.7

2.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.39

1.82

23.3

23.0

128.67

129.56

g/l

0.04

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

112

1.98

1.81

3.8

4.6

0.23

0.22

g/l

0.31

103

(3013650) Neutrophils [#/volume] in Blood by Automated count

561

1.74

1.76

16.3

12.7

3.73

3.84

e9/l

0.14

452

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2.34

1.75

3.6

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.15

1.75

1.5

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

2.00

1.71

5.6

5.2

54.64

66.55

e9/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.60

1.70

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2.93

1.68

2.0

1.5

34.86

40.36

nmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.93

1.68

2.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.93

1.68

2.1

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.53

1.67

1.1

1.3

—

(3042936) Bacteria identified in Isolate by Culture

139

1.85

1.67

3.4

2.0

—

(3011648) Oxygen content in Venous blood

2.63

1.63

9.8

27.3

10.59

12.00

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.26

1.62

1.9

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

142

1.80

1.56

5.5

3.6

295.21

520.77

ng/l

0.41

(42529406) Shigella sp [Presence] in Stool by Culture

2.71

1.54

4.1

1.1

—

(3049717) Cytology report of Urine Cyto stain

3.45

1.54

3.4

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

111

1.88

1.52

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.83

1.46

2.2

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

3.23

1.45

2.8

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

170

1.72

1.45

3.8

4.2

1.87

2.72

mg/l

0.30

142

(3024928) Oxygen saturation in Venous blood

2.37

1.44

8.9

24.8

69.99

69.87

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

331

1.59

1.43

1.9

1.8

0.49

4.96

u/ml

1.91

(3041096) Erythrocytes [Presence] in Urine by Automated

224

1.63

1.39

5.4

2.7

0.00

estimate

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.98

1.38

7.2

8.7

91.36

90.74

0.03

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

3.04

1.37

4.2

6.5

83.80

99.71

—

(3020393) Adenovirus Ag [Presence] in Stool

3.04

1.37

1.4

2.6

—

(3015736) pH of Urine

381

1.56

1.37

5.1

3.4

6.14

6.25

0.26

197

(3019977) pH of Arterial blood

1.92

1.36

41.0

13.4

7.40

7.41

—

(44790047) Parainfluenza type 1 nucleic acid detection

2.20

1.34

4.0

2.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

2.20

1.34

4.0

2.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

2.20

1.34

4.0

2.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

2.20

1.34

4.0

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.06

1.34

5.3

8.1

167.58

177.89

0.20

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

365

1.54

1.30

5.0

3.3

—

estimate

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2.08

1.27

2.2

3.8

4.61

5.02

pmol/l

0.75

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.33

1.27

2.8

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.33

1.27

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.71

1.23

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

195

1.61

1.23

9.1

3.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.20

1.21

9.9

23.5

67.88

70.11

—

(3034770) Mitochondria Ab [Titer] in Serum

2.39

1.20

1.2

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.39

1.20

2.3

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.07

1.16

8.1

21.7

0.49

0.53

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.35

1.13

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.97

1.12

1.9

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2.03

1.11

1.0

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.27

1.10

3.3

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.27

1.10

1.6

2.1

—

(3028300) Cannabinoids [Presence] in Urine

1.90

1.10

1.2

2.2

—

(3027008) Opiates [Presence] in Urine

1.90

1.10

1.2

2.1

—

(36660697) Celiac disease serology panel - Serum

158

1.59

1.06

1.6

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1.87

1.06

1.2

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.00

1.05

1.7

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.07

1.02

1.3

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.92

1.02

3.2

1.5

—

(3027944) Amphetamines [Presence] in Urine

1.84

1.01

1.2

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

518

1.46

1.01

5.8

4.5

34.82

36.41

u/l

0.09

502

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.01

0.99

3.3

1.7

—

(4024509) Urine culture

0.00

0.99

0.0

1.6

—

(40768804) Tissue Pathology biopsy report

260

1.47

0.96

2.3

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

251

1.47

0.96

2.2

1.9

88.20

92.43

pmol/l

0.22

143

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.14

0.91

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

130

1.57

0.89

2.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

2.06

0.88

1.0

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

2.06

0.88

3.5

4.3

37.63

38.40

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

311

1.42

0.88

5.1

3.1

0.00

estimate

—

(3013512) EKG study

174

1.50

0.88

4.5

3.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.84

0.87

1.2

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.80

0.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.73

0.77

2.1

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.73

0.77

1.1

2.5

—

(3019150) Specific gravity of Urine by Refractometry

197

1.43

0.76

3.6

3.4

1.02

kg/l

1.21

127

(3028707) Methadone [Presence] in Urine by Screen method

1.90

0.75

1.1

2.0

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

596

1.38

0.74

7.4

4.4

12.20

8.78

mm/h

0.77

558

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.05

0.74

1.0

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.61

0.72

67.4

16.1

0.67

0.63

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.97

0.71

3.0

4.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.97

0.71

1.2

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

578

1.36

0.70

30.2

11.0

80.11

91.46

ml/min/173m2

1.93

512

(3019832) Treponema pallidum Ab [Presence] in Serum

138

1.47

0.69

2.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

187

1.37

0.60

2.4

3.1

19.05

25.53

ng/l

0.35

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.55

0.60

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

0.56

0.59

1.0

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.5

—

6.28

—

(3002256) Pathology report gross observation

1.51

0.59

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.76

0.59

1.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.76

0.59

1.0

1.3

—

(3016879) Cocaine [Presence] in Urine

1.60

0.58

1.2

2.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.58

0.57

67.4

16.1

94.56

94.35

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.55

0.56

67.4

15.7

1.18

1.21

—

(3003694) ABO and Rh group [Type] in Blood

283

1.31

0.56

1.8

1.6

—

(1002224) Polysomnography panel

1.62

0.55

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.57

0.54

1.0

1.4

—

0.33

—

(3029937) Albumin [Presence] in Urine by Test strip

212

1.31

0.49

5.2

3.1

0.00

estimate

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.64

0.43

1.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.59

0.43

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.39

0.42

5.2

1.9

—

(4034850) Laboratory test

0.00

0.41

0.0

6.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

1.80

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

3.4

—

22.57

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

217

1.27

0.41

36.4

20.5

25.00

24.27

mmol/l

0.56

217

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.41

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.40

0.0

5.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

134

1.32

0.40

1.5

1.3

1.22

7.49

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.41

0.39

1.2

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

305

1.23

0.38

2.1

1.8

—

(3017732) Neutrophils [#/volume] in Blood

123

0.71

0.38

3.2

3.3

3.85

6.20

e9/l

—

111

(3000494) Fungus identified in Specimen by Culture

109

1.33

0.36

3.2

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.42

0.36

1.0

157.00

163.42

g/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

204

1.23

0.33

7.3

6.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

235

0.81

0.30

2.0

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.65

0.27

2.2

2.0

—

(3022145) Colonoscopy Study observation

1.24

0.26

2.3

1.4

—

(3009343) pH of Capillary blood

200

1.19

0.25

25.8

12.8

7.40

0.05

152

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.31

0.25

6.1

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

144

1.22

0.24

1.5

1.3

10.87

27.36

iu/ml

—

(3006598) pH of Arterial cord blood

1.30

0.23

1.0

—

(3022313) Gas panel - Capillary blood

174

1.19

0.22

26.4

12.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

203

1.17

0.21

3.2

2.2

115.30

175.22

u/l

0.98

197

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

0.70

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

1.39

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.21

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

0.00

0.21

0.0

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.17

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.21

0.0

1.5

—

(3008898) HLA-B27 [Presence]

1.24

0.19

1.1

1.0

—

(3000492) Spirometry study

0.79

0.16

4.0

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

103

1.19

0.14

1.3

1.5

—

(40761536) Microorganisms panel - Urine sediment

1.12

0.09

7.5

2.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.04

0.08

2.8

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1.08

0.08

1.7

1.8

3.16

3.48

mmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.81

0.08

2.0

1.5

1507.37

911.36

mu/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

111

0.89

0.06

2.6

1.6

556.90

111429011.10

pmol/l

—

105

(40761511) CBC panel - Blood by Automated count

861

0.91

0.06

25.1

11.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

144

1.05

0.00

5.5

2.3

—

(1761868) Lipid panel - Serum or Plasma

269

1.01

0.00

2.6

2.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

156

1.03

0.00

5.7

2.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

21.8

—

861.56

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

4.4

—

2.71

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

148.11

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.0

2.4

—

10.67

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

23.0

—

1424.00

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

315.50

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

127.18

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

7.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

293.25

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

-0.00

0.0

1.9

—

24.99

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

3.5

—

19.33

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.8

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.68

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

1.01

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.96

-0.00

1.9

3.31

3.44

ratio

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.91

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

1.22

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

3.33

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

4.0

—

0.71

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

4.02

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.4

—

1099.20

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

20.6

—

0.77

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

1.41

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

1298.00

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

1.12

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

6.8

—

(40768797) Stomach Pathology biopsy report

0.96

-0.00

1.2

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.78

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.72

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA – Need for immunization against single bacterial diseases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Need for immunization against single bacterial diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Need for immunization against single bacterial diseases (Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints